GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma. (2020)

First Author: Negroni C

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ebiom.2020.102941

PubMed Identifier: 32810829

Publication URI: http://europepmc.org/abstract/MED/32810829

Type: Journal Article/Review

Volume: 59

Parent Publication: EBioMedicine

ISSN: 2352-3964